Table. Characteristics of Participants at Baseline.
| Characteristic | No. (%)a | P value | |
|---|---|---|---|
| Telmisartan (n = 106) | Placebo (n = 101) | ||
| AAA diameter, mmb | |||
| Mean (SD) | 43.3 (4.8) | 43.1 (5.2) | .71 |
| Level | |||
| <40 | 26 (25) | 28 (28) | .87 |
| 40 to <45 | 41 (39) | 38 (38) | |
| ≥45 | 39 (37) | 35 (35) | |
| Age, y | |||
| Mean (SD) | 73.2 (8.1) | 73.8 (7.8) | .61 |
| Group, y | |||
| <70 | 39 (37) | 35 (35) | .69 |
| 70 to <80 | 46 (43) | 41 (41) | |
| ≥80 | 21 (20) | 25 (25) | |
| Sex | |||
| Male | 92 (87) | 91 (90) | .46 |
| Female | 14 (13) | 10 (10) | |
| Region | |||
| Australia | 61 (58) | 55 (54) | .89 |
| The Netherlands | 35 (33) | 35 (35) | |
| US | 10 (9) | 11 (11) | |
| Prior disease | |||
| Cardiovascular diseasec | 59 (56) | 48 (48) | .24 |
| Diabetes | 11 (10) | 12 (12) | .73 |
| Smoking status | |||
| Current | 23 (22) | 27 (27) | .70 |
| Previous | 75 (71) | 67 (66) | |
| Never | 8 (8) | 7 (7) | |
| Systolic blood pressure, mm Hgd | |||
| Mean (SD) | 139 (17) | 136 (17) | .14 |
| Level | |||
| <130 | 33 (31) | 42 (42) | .10 |
| 130 to <140 | 22 (21) | 25 (25) | |
| ≥140 | 51 (48) | 34 (34) | |
| Diastolic blood pressure, mm Hg | |||
| Mean (SD) | 80 (10) | 78 (9) | .18 |
| Level | |||
| <80 | 55 (52) | 54 (53) | .45 |
| 80 to <90 | 32 (30) | 35 (35) | |
| ≥90 | 19 (18) | 12 (12) | |
| Waist-to-hip ratioe | |||
| Mean (SD) | 1.00 (0.07) | 1.00 (.07) | .55 |
| Level | |||
| ≤0.95 | 21 (20) | 17 (17) | .85 |
| >0.95 to <1.0 | 26 (25) | 25 (25) | |
| ≥1.0 | 59 (56) | 59 (58) | |
| Glomerular filtration rate, mL/min/1.73 m2 | |||
| Mean (SD) | 75 (17) | 77 (16) | .34 |
| Level | .63 | ||
| <60 | 15 (14) | 12 (12) | |
| ≥60 | 91 (86) | 89 (88) | |
| Medications | |||
| Antiplatelet agent | 65 (61) | 57 (56) | .48 |
| Statin | 69 (65) | 66 (65) | .97 |
| β-Blocker | 24 (23) | 21 (21) | .75 |
| Calcium channel blocker | 12 (11) | 14 (14) | .58 |
| Diuretic | 13 (12) | 9 (9) | .43 |
Abbreviation: AAA, abdominal aortic aneurysm.
a
Percentages may not total 100 because of rounding.
b
Maximum infrarenal aortic diameter as reported by participating sites (rather than core lab-measured AAA diameter).
c
Includes participants with a documented history of coronary heart disease, stroke, or peripheral artery disease.
d
P value calculated using nonparametric testing.
e
Not measured in 3 participants (1.4%).